Home > Financial Ratios > AARTI PHARMALABS

AARTI PHARMALABS
EV/Core EBITDA

    Back to All Ratios
AARTI PHARMALABS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for AARTI PHARMALABS
Please provide your vote to see the results

AARTI PHARMALABS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 10.707.811.22-3.76

What is the latest EV/Core EBITDA ratio of AARTI PHARMALABS ?

The latest EV/Core EBITDA ratio of AARTI PHARMALABS is 10.70 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202410.70
Mar20237.81
Mar20221.22
Mar2021-3.76

How is EV/Core EBITDA of AARTI PHARMALABS Trending?

Years EV/Core EBITDA % Change
Mar2024 10.7
37.00
Mar2023 7.81
540.16
Mar2022 1.22
Positive
Mar2021 -3.76 -

Other Financial Ratios of AARTI PHARMALABS


Compare EV/Core EBITDA ratio of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹7,752.6 Cr -1.4% -7.5% 40.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹389,172.0 Cr -1.2% -3.6% -8.6% Stock Analytics
DIVIS LABORATORIES ₹158,248.0 Cr -6.6% -12.4% 22.3% Stock Analytics
CIPLA ₹122,835.0 Cr 0.3% 1.2% -5.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,793.0 Cr 0.7% 9.1% 7.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,869.0 Cr 0.4% -2.8% -12.7% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

-1.4%

-7.5%

40.1%

SENSEX

-0.6%

-2.8%

1.7%


You may also like the below Video Courses